Talk:Central serous chorioretinopathy

Sub

Sub-retinal neovascularisation is not a clearly proven complication of CSR. It may occur if laser photocoagulation has been done for the treatment of CSR.

Regarding the longterm follow-up and outcome of CSR, no adequate figures are available.

The cited 50% severe visual loss is based on a study of 6 patients (11 eyes), which where followed for a long time. [reference 9]

Not only is this number extremely low, only patients with a sufficient long term follow up could be included in this study. This probably is a subgroup of patients with persisting CSR related problems, or concommitant eye diseases. Most CSR patients are discharged from clinics within 3 to 12 months of follow up.

CSR is not restricted to males.

External links

External links on Wikipedia are supposed to be "encyclopedic in nature" and useful to a worldwide audience. Please read the external links policy (and perhaps the specific rules for medicine-related articles) before adding more external links.

The following kinds of links are inappropriate:

• Online discussion groups or chat forums
• Personal webpages and blogs
• Multiple links to the same website
• Fundraising events or groups
• Websites that are recruiting for clinical trials
• Websites that are selling things (e.g., books or memberships)

I realize that some links are helpful to certain users, but they still do not comply with Wikipedia policy, and therefore must not be included in the article. WhatamIdoing (talk) 07:49, 17 January 2008 (UTC)

Treatment hokum

Cleverly worded statement, "CSR sufferers usually find their own ways to manage the condition, which may include stress reduction and changes in nutrition." with reference cited (to non-encyclopeadic personal web page) may lead one to believe that this is an effective course of treatment. I'm tempted to edit the article and put it more bluntly with something along the lines of, "Faced with an untreatable condition of unclear origin, some patients grasp for dietary and lifestyle changes as possible panaceas." But that would be cynical, wouldn't it? The cleverly worded statement stands. —Kvng (talk • contribs) 04:58, 6 August 2008 (UTC)

Removed in 2011 ~Kvng (talk) 17:38, 8 April 2020 (UTC)

Marijuana Assertion

Can we just take this out? I can't find a citation anywhere. NBeddoe (talk) 11:04, 30 November 2009 (UTC)

Doesn't look like anyone is going to come up with one. Participation in a study is not notable. I have deleted the marijuana reference. --Kvng (talk) 06:13, 26 July 2010 (UTC)

New references

New information to be incorporated in the article --Kvng (talk) 06:13, 26 July 2010 (UTC)

• André Maia, MD, PHD (February 2008). "A New Treatment for Chronic Central Serous Retinopathy". Retina today. Retrieved 2010-07-25.{{cite web}}: CS1 maint: multiple names: authors list (link)

Evaluation: This is not a peer-review source. CSC is easy to treat with any laser at low power. This anecdotal report is not a serious clinical trial. Storslem. —Preceding unsigned comment added by Storslem (talk • contribs) 22:25, 27 November 2010 (UTC)

• MICHAEL COLUCCIELLO, MD (September 2008). "Central Serous Retinopathy". Retinal Physician. Retrieved 2010-07-25.
• http://health.groups.yahoo.com/group/csreye/files/
• http://www.vrmny.com/pe/csc.html
• http://www.mdsupport.org/library/csr.html
• http://www.iridex.com/Portals/0/physician-education/pdf/Maia%20A%20new%20treatment%20for%20chronic%20CSR%20Retina%20Today%202010.pdf
• http://bmctoday.net/retinatoday/2010/04/article.asp?f=when-to-treat-and-not-to-treat-patients-with-central-serous-retinopathy
• http://www.sciencedirect.com/science/article/pii/S1350946215000336